An article titled ‘Race matters for breast cancer screening protocols,’ was published last month on AuntMinnie.com. The article highlights a study published online in JAMA Surgery that examined the age distribution of breast cancer diagnosis in the United States across race and ethnicity. The intention of the study was ...

Today two widely respected and accomplished breast cancer investigators join the ranks of an esteemed group of scientists as recipients of this year’s Brinker Awards – the highest scientific honor awarded by Susan G. Komen, the world’s leading breast cancer organization.   Established by Komen ...

Women who receive a breast cancer diagnosis while they are still young enough to bear children can take time to freeze their eggs and embryos without fear of delaying their cancer treatment, according to research by UC San Francisco scientists who have helped develop a ...

A molecular test can pinpoint which patients will have a very low risk of death from breast cancer even 20 years after diagnosis and tumor removal, according to a new clinical study led by UC San Francisco in collaboration with colleagues in Sweden. As a result, “ultralow” risk patients could be treated less aggressively and overtreatment avoided, leading to fewer toxic effects.

Asian-American women are more likely to experience delays in follow-up treatment after an abnormal mammogram compared to white women, according to new UC San Francisco research.

A goal of precision medicine for cancer is to match patients with the most appropriate treatments based on information about the genetic and molecular changes in their tumors. This approach can also help patients avoid treatments that would be unlikely to help and could cause harm.